Abstract |
Our recent study reported that amylin, a pancreatic peptide that readily crosses the blood-brain barrier, improves learning and memory in Alzheimer's disease mouse models. However, the relationship between peripheral amylin and cognition in humans is unknown. In this follow-up study, using a cross-sectional, homebound elderly population, improvement in cognitive function with increasing quartiles of plasma amylin was suggested by positive association with verbal memory (p = 0.0002) and visuoconstruction tasks (p = 0.004), and inverse association with timed measures of attention (p < 0.0001) and executive function (p = 0.04). After adjusting for demographic information, apolipoprotein E4 allele, diabetes, stroke, kidney function, and lipid profile, log10 of plasma amylin remained associated with these cognitive domains. In contrast, plasma amyloid-β peptide was not associated with these specific cognitive domains. Our study suggests that peripheral amylin may be protective for cognitive decline, especially in the domains affected by Alzheimer's disease.
|
Authors | Wei Qiao Qiu, Rhoda Au, Haihao Zhu, Max Wallack, Elizabeth Liebson, Huajie Li, James Rosenzweig, Mkaya Mwamburi, Robert A Stern |
Journal | Journal of Alzheimer's disease : JAD
(J Alzheimers Dis)
Vol. 42
Issue 2
Pg. 555-63
( 2014)
ISSN: 1875-8908 [Electronic] Netherlands |
PMID | 24898659
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Apolipoproteins E
- Islet Amyloid Polypeptide
|
Topics |
- Aged
- Aged, 80 and over
- Amyloidosis, Familial
(blood)
- Apolipoproteins E
(genetics)
- Attention
(physiology)
- Cognition
(physiology)
- Community Health Planning
- Corneal Dystrophies, Hereditary
(blood)
- Female
- Genotype
- Geriatric Assessment
- Home Care Services
(statistics & numerical data)
- Humans
- Islet Amyloid Polypeptide
(blood)
- Learning
(physiology)
- Male
- Mental Status Schedule
- Neuropsychological Tests
- Verbal Behavior
(physiology)
|